SCHEMBL32665613

SCHEMBL32665613

O=C(c1cccc(OCc2ccccc2)c1)N1CCC(O)CC1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.72
PDE3B Q13370 1/20 0.60
PDE3A Q14432 1/20 0.60
NAAA Q02083 1/20 0.60
NR4A2 P43354 1/20 0.59
MAOB P27338 1/20 0.56
MGLL Q99685 5/20 0.56
SMPD1 P17405 1/20 0.54
SRD5A2 P31213 1/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
TP53 P04637 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
LMNA P02545 1/20 0.53
HTT P42858 1/20 0.53
RECQL P46063 1/20 0.53
SPHK2 Q9NRA0 1/20 0.53
KDM2B Q8NHM5 1/20 0.53
PTPN1 P18031 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22688327 1.00 ALDH1A1 (0.72) ALDH1A1PDE3BPDE3ANAAANR4A2
SCHEMBL24304100 0.86 ALDH1A1 (0.67) ALDH1A1NAAANR4A2MAOBMGLL
SCHEMBL11085975 0.84 ALDH1A1 (0.74) ALDH1A1NAAANR4A2MAOBMGLL
SCHEMBL32665570 0.82 ALDH1A1 (0.61) ALDH1A1PDE3BPDE3ANAAANR4A2
SCHEMBL32665324 0.79 ALDH1A1 (0.58) ALDH1A1PDE3BPDE3ANAAANR4A2
SCHEMBL3354512 0.79 ALDH1A1 (0.57) ALDH1A1PDE3BPDE3ANAAANR4A2
SCHEMBL22864871 0.79 ALDH1A1 (0.67) ALDH1A1NAAANR4A2MAOBMGLL
SCHEMBL22864867 0.79 ALDH1A1 (0.67) ALDH1A1NAAANR4A2MAOBMGLL
SCHEMBL4321888 0.78 MEN1 (0.78) ALDH1A1MGLLRAB9ASMN1; SMN2LMNA
SCHEMBL13097312 0.78 NPC1 (0.58) NR4A2MAOBNPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A ALDH1A1 3714/4885PDE3B 4874/4885PDE3A 4881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.